Events › Healthcare & MedTech
Healthcare & MedTech
230
Exhibitors
1,600
Attendees
Nordic Life Science Days is the largest Nordic partnering conference for the global life science industry, focusing on biotech, pharma, medtech, and digital health.
Attendees: Biotech, pharma, medtech executives, investors, researchers, business development professionals.
Exhibitor mix: Categorized by Biotechnology, CRO/CMO/CDMO, Drug Discovery, Genetics, Professional Services, and International Delegations.
Filter this event to your ICP.
230 exhibitors here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
Venue
KistamässanMultipurpose · 8,500 m² · 2 halls · ~2,500 people
A modern exhibition and convention centre in Stockholm (Kista), Sweden, featuring flexible halls and meeting rooms for trade fairs, congresses, and large-scale corporate events.
📍 Arne Beurlings Torg 5, 164 40 Kista, Sweden
Operated by Easyfairs
Organizer
SwedenBIO Service AB
Nonprofit · Stockholm, Sweden · Founded 2002
The national industry organization for the life science sector in Sweden, working to strengthen the industry and create growth through advocacy and networking.
Exhibitor list
28 companies are exhibiting at Nordic Life Science Days. A sample of 12 is shown below — unlock the full list to see all 28.
16 more exhibitors at Nordic Life Science Days.
Unlock the complete exhibitor list — every company, with optional ICP filtering and verified buying-committee contacts per matched account.
Why people attend
1-to-1 partnering, licensing opportunities, investment, and networking with Nordic and global biotech/pharma leaders.
Exhibitor categories
Speakers
56 speakers at Nordic Life Science Days
Head of AZ BioVenture Innovation Unit & CEO AZ BioVentureHub · AstraZeneca
European Investment Bank
"Growth capital and Venture Debt"
Principal · Sound Bioventures
Ester Sklarsky is an investment professional in life sciences, currently at Sound Bioventures, a Scandinavian biotech venture capital fund. Prior to joining the firm, she spent over two years at Industrifonden, where she worked across the investment lifecycle, managing deal flow and performing scientific and strategic due diligence for early-stage biotech ventures. Ester began her career in management consulting at Sirona Health Solutions, advising key stakeholders in the Swedish public healthcare sector. She also gained experience as an equity analyst at DNB, with a dedicated focus on the biotech sector. She holds a B.Sc. in Biomedicine and an M.Sc. in Bioentrepreneurship, both from the Karolinska Institute in Stockholm.
Also speaking at BioFIT
NHSBT
Also speaking at British Blood Transfusion Society Annual Conference
Principal · Lundbeckfonden BioCapital
Kevin Dalgaard is a Principal at Lundbeckfonden BioCapital, the venture capital team of the Danish enterprise foundation, Lundbeckfonden, where the focus is to invest in and build companies within life sciences. Prior to joining the foundation Kevin worked at Novo Nordisk and Boehringer Ingelheim for several years in various positions within R&D, Global Marketing, and Business Development providing him a great insight and understanding of the whole value chain in the pharma industry. Kevin holds an MSc in Biochemistry from the University of Copenhagen, and a Ph.D. from Max Planck Institute. Kevin has several high-impact publications including a first-author publication in ‘Cell’.
Also speaking at BioFIT
University of Oslo
"ProClass – A Molecular Classifier Independent of Heterogeneity in Primary Prostate Cancer"
University of Oslo
"Early Cancer Detection in a Simple Blood Test"
+ 40 more speakers at this event.
More Healthcare & MedTech events
Frequently asked questions